FIELD: ophthalmology. SUBSTANCE: invention is distinguished by that known ocular drops containing, wt %: sodium succinate hexahydrate, 1.91; sodium citrate 5.5-hydrate, 0,40; sodium chloride, 0.31; sorbitol, 0.80; L-glutamic acid, 0.015; benzalkonium chloride, 0.014; riboflavin mononucleotide phosphate, 0.02; and water, the balance, additionally contain glucose, 0.30. In one of the versions of invention, ocular drops additionally contain taurine in quantity of 0.4 g per 100 ml. EFFECT: extended choice of therapeutic means. 2 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
EYE DROPS | 1997 |
|
RU2121825C1 |
OCULAR DROPS "PYROTONIK" | 1997 |
|
RU2127100C1 |
EYE DROPS | 1993 |
|
RU2056821C1 |
PHARMACEUTICAL ANTIGLAUCOMA COMPOSITION | 2009 |
|
RU2402316C2 |
COMBINED OPHTHALMIC PREPARATION PRESENTED IN FORM OF EYE DROPS AND CONTAINING POLYHEXAMETHYLENE GUANIDINE AND TAURINE | 2012 |
|
RU2513997C1 |
DISULFIRAM AND TAURINE-CONTAINING OPHTHALMOLOGICAL MEDICATION IN FORM OF EYE DROPS | 2012 |
|
RU2485939C1 |
UNIVERSAL REMEDY FOR HYPOTHERMIC PRESERVATION OF CORNEA GRAFT | 2019 |
|
RU2710167C1 |
OPHTHALMOLOGIC GEL OF TAURINE | 2016 |
|
RU2623205C1 |
COMBINED OPHTHALMIC AGENT | 2019 |
|
RU2733392C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING EYE DISEASES RELATED TO EYE TISSUE METABOLIC DISEASE AND INFLAMMATORY EYE TISSUE INJURY | 2013 |
|
RU2521337C1 |
Authors
Dates
1999-03-10—Published
1997-04-07—Filed